ALLARTA
Live / Applied — First extension granted (statement of use) (as of 25 Aug 2026)
What this means for you
Not registered yet, but its 18 Feb 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99042716
- Mark type
- Stylized text
- Filed
- 18 Feb 2025
- Published for opposition
- 09 Dec 2025
- Attorney of record
- Brian Chau
Goods and services
- Class 001 — Chemicals: Chemical agents for scientific research use, namely, macromolecules for the purpose of scientific research about supporting the viability and function of therapeutic transplants including medical device and cell therapy transplants, for use in the scientific research about discovery of new methods regarding implantable medical devices and cell therapies
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of endocrine diseases and oncological diseases; stem cells for medical purposes; stem cells and progenitor cells for medical purposes, specifically, for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system; stem cells and progenitor cells for medical purposes, specifically, for use in the production of biologic substances, namely, growth factors and proteins; Hormone replacement therapy preparations; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in cell therapy; pharmaceutical preparations for use in immunomodulation therapies; surgical implants comprised of living tissues; surgical implants comprising living tissue, namely, surgical implants grown from stem cells; Chemical agents for medical use, namely, macromolecules for the purpose of supporting the viability and function of therapeutic transplants including medical device and cell therapy transplants, for use in the development of implantable medical devices and cell therapies; chemical agents for medical purposes, namely, the coating of implantable medical devices and for encapsulating pharmaceutical agents and cells for the purpose of supporting the viability and function of therapeutic transplants including medical device and cell therapy transplants
- Class 010 — Medical apparatus: Implants consisting of artificial materials for medical use and diagnostic use; coatings sold as an integral component of implantable medical devices, namely, coatings comprised of polymers and chemical compounds
- Class 042 — Scientific and technological services: Research and development of immune system treatments; Medical and scientific research in the field of stem cell therapy and cell transplantation therapies; Medical research; biopharmaceutical development, research and product evaluation of stem cell-based therapeutics for the treatment of diseases and disorders; Laboratory services for the production of therapeutical cellular products and the active ingredients for cell based therapies
- Class 044 — Medical, beauty and agricultural services: Medical treatment using cultured cells; stem cell therapy services
Owner
- Allarta Life Science Inc., Hamilton, Ontario, ON, CA
- Allarta Life Science Inc., Dundas, ON, CA
Prosecution history
- 09 Sept 2026 — TEAS PETITION TO DIRECTOR RECEIVED
- 09 Sept 2026 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 25 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Aug 2026 — SOU EXTENSION 1 GRANTED
- 16 Jul 2026 — SOU EXTENSION 1 FILED
- 24 Aug 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Aug 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Aug 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 16 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Feb 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Dec 2025 — PUBLISHED FOR OPPOSITION
- 03 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER